These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38510674)

  • 1. Chronic ocular small vessel disease: An overview of diabetic retinopathy and its relationship with cardiovascular health.
    Iyer SSR; Radhakrishnan NS; Roohipourmoallai R; Guerin CM; Maylath JS; Garson N
    Am Heart J Plus; 2023 May; 29():100270. PubMed ID: 38510674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
    Mudaliar S; Hupfeld C; Chao DL
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
    Ajlan RS; Silva PS; Sun JK
    Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies.
    Thomas L; Low S; Hansen G; Bakker RA; Zippel N
    J Pharmacol Exp Ther; 2023 Jun; 385(3):214-221. PubMed ID: 36997325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vascular endothelial growth factor for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Evans JR
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novelties in Diabetic Retinopathy.
    Ebneter A; Zinkernagel MS
    Endocr Dev; 2016; 31():84-96. PubMed ID: 26824524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evolving Treatment of Diabetic Retinopathy.
    Mansour SE; Browning DJ; Wong K; Flynn HW; Bhavsar AR
    Clin Ophthalmol; 2020; 14():653-678. PubMed ID: 32184554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Microaneurysms in the Pathogenesis and Therapy of Diabetic Macular Edema: A Descriptive Review.
    Takamura Y; Yamada Y; Inatani M
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984436
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy.
    Tang L; Xu GT; Zhang JF
    Neural Regen Res; 2023 May; 18(5):976-982. PubMed ID: 36254977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab for the treatment of diabetic retinopathy.
    Chatziralli I
    Expert Opin Biol Ther; 2021 Aug; 21(8):991-997. PubMed ID: 33966556
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group.
    AlQahtani AS; Hazzazi MA; Waheeb SA; Semidey VA; Semidey VA; Elgendy HK; Alkhars WI; Abouammoh MA; Al-Dhibi H
    Saudi Med J; 2021 Feb; 42(2):131-145. PubMed ID: 33563731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Intravitreal Injection of Anti-vascular Endothelial Growth Factor Drugs on Ocular Blood Vessels and Blood Flow in Patients with Diabetic Retinopathy].
    Huang H; Shi L; Li S; Wu N; Rao J; Wu YJ; Wu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):796-800. PubMed ID: 34728042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging the Retinal Vascular Mural Cells In Vivo: Elucidating the Timeline of Their Loss in Diabetic Retinopathy.
    Huang BB; Fukuyama H; Burns SA; Fawzi AA
    Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):465-476. PubMed ID: 38152885
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.